Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine... (novative manufacturing solution. We app...)

Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico

Date:10/20/2009

novative manufacturing solution. We appreciate having the opportunity and support to demonstrate the H1N1 vaccine's safety, immunogenicity and efficacy in Mexico and thereby help with ongoing pandemic response efforts. Similar to our previous announcements regarding our ongoing work in the countries of India and Spain, where we plan to establish in-border production, our planned clinical work in Mexico, if successful, could lead to rapid availability of the vaccine and advance Novavax's regional strategy to assist countries around the globe with such critical needs."

Virus-like particles (VLPs) mimic the external structure of viruses but lack the live genetic material that causes viral replication and infection. VLPs can be designed quickly to match individual viral strains and be produced efficiently using portable cell-culture technology. Novavax's VLP-based vaccine candidates are produced significantly more quickly than egg-based vaccines by using proprietary, portable, recombinant cell-culture technology.

The company will hold an investor conference call to discuss this clinical study at 9:00 a.m. Eastern Time on Tuesday, October 20, 2009. The call will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of the company's senior management team. A question and answer session will follow. The dial-in number for the conference call is 1 (866) 206-5917 (International: 1 (703) 639-1106). A live audio webcast of the conference call will be available at www.novavax.com under Investors/Events. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast.

A replay of the webcast will be available on the website for 90 days after the call and a replay of the conference call will also be available by telephone beginning October 20, 2009 at
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
2. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
3. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
4. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
5. Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
6. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
7. NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting
8. NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
9. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development

Post Your Comments:

(Date:6/19/2013)... June 19, 2013 BioCision , a ... and handling in many areas of medical and ... patents by the U.S. Patent Office that apply ... to standardize sample handling to ensure the consistency ... common laboratory procedures. Patent number ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ -- Chindex International, ... American healthcare company providing services in ... Family Healthcare, a network of private hospitals and ... of its Beijing United Family Rehabilitation Hospital ("BJU ... of the United Family Healthcare ("UFH") network. On ...

(Date:6/19/2013)... , June 19, 2013 DST Health Solutions, ... services to health plans, integrated delivery systems, and health ... Medical Drug Management Service (MDMS) has jumped significantly. ... and automate the pricing of medical prescription drug claims, ... by automating their medical drug claims processes. As specialty ...

Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5 Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2 Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3

[0] BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research [0] Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital [0] Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase

... NEW YORK, May 24, 2011 Reportlinker.com ... is available in its catalogue: ... Angiogenesis http://www.reportlinker.com/p0284984/Triple-Analysis-Lung-Cancer-Lymphoma-and-Angiogenesis.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... on cancer drug development strategies in both ...

... YORK, May 24, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0284621/Triple-Analysis-Leukemia-Lymphoma-and-Peptides.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... development strategies in both Leukemia and Lymphoma ...

Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides

(Date:6/19/2013)... (PRWEB) June 19, 2013 ... of neurologists, neurosurgeons, psychiatrists and urologists with specialists ... The team works with patients and their family ... overall quality of life. Patients also have the ... trials and research. , “Movement disorders can be ...

(Date:6/19/2013)... YOKOHAMA, Japan Leading Japanese pharmaceutical companies, along ... Melinda Gates Foundation, pledged their commitment to bolster ... Health Innovative Technology Fund (GHIT Fund), at a ... the fifth Tokyo International Conference on African Development ... partners including the Ministry of Health, Labour ...

(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...

(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...

(Date:6/19/2013)... City, MO (PRWEB) June 19, 2013 Kansas City ... part of Main Street Day . A section of Main ... pedestrian traffic during the afternoon of the event. The Main ... host the event, which will help Kansas City join the ranks ... used Ciclovia as a tool to foster community vibrancy and active ...

Breaking Medicine News(10 mins):Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2 Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 2 Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 3 Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2 Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2 Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3 Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2 Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3

[0] Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center [0] GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health [0] Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers [0] Brightree Debuts on List of Top 100 Healthcare Technology Companies [0] Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia

... access to medical product company,s industry-leading, non-invasive temperature therapy ... ... Tenn., May 29 Adroit Medical Systems, Inc.,today announced its award ... agreement centers on Adroit,s leading,Soft-Temp(R) hypo-hyperthermia blankets, localized heat therapy and ...

... Participating in Outdoor Activities, OFF!(R) Finds ... Uninterrupted, and Your ... sure do know how to make,the most out of their ... their families plan to attend a barbeque,(73 percent), watch fireworks ...

... ... Treatments, LAS ... and marketer of laser, light, and radiofrequency based,aesthetic devices, announced today ... platform for multiple aesthetic laser and,light treatments. The Harmony(XL) can be ...

... May 29 Darwin (NYSE: DR ),is ... product-centric underwriting,divisions, the health care division and the ... ), Under the leadership of senior ... newly created health care division combines all,of Darwin,s ...

... and complex condition that impacts about 15% of the ... known about the mechanisms behind the psychiatric disorder. ... parallels between depressive symptoms and the symptoms of certain ... in Molecular Psychiatry, researchers from University of Miami found ...

... to Cover ... Lost Income, NEW YORK, ... that U.S. employees are just,as concerned about the possibility of losing their ... to a recent survey,from Berkshire Life Insurance Company of America (Berkshire), a,wholly-owned ...

Adroit Medical Systems Awarded Premier Supplier Contract for Temperature Therapy Systems Keep Your Cool and Sanity This Summer!Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008 Darwin Announces Creation of New Health Care and Errors and Omissions Divisions Inflammation, depression and antidepressant response: Common mechanisms Guardian Survey: Fear of Losing Income Due to the Economy Equals Fear of Losing Income Due to Disability

Colloidal Gold Conjugated, Goat anti-human IgG (H&L) - 50 OD...

Colloidal Gold Conjugated, Goat anti-human IgA (Alpha Chain) - 50 OD...

Polyester ribbons (3) impregnated with different OD values of conjugated Protein A...

Polyester ribbon impregnated with conjugated Protein A - .13 OD per sq. cm....

Medicine Products:

Goat Anti-Human IgG (H & L) Antibody, Colloidal Gold Conjugated, 50 OD Goat Anti-Human IgA, alpha chain Antibody, Colloidal Gold Conjugated, 50 OD Protein A Sample Pack - .13 OD ; .25 OD; .50 OD per sq. cm Protein A, Gold Ribbon - .13 OD per sq. cm.